SCHEMBL3273068

SCHEMBL3273068

COC(=O)c1ccccc1NC1=CC(=O)C(=O)c2ccccc21

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APAF1 O14727 8/20 0.72
KMT2A Q03164 8/20 0.72
CASP3 P42574 7/20 0.72
SENP8 Q96LD8 7/20 0.72
SENP7 Q9BQF6 7/20 0.72
SENP6 Q9GZR1 7/20 0.72
MAPT P10636 7/20 0.72
KDM4E B2RXH2 7/20 0.72
HKDC1 Q2TB90 4/20 0.72
TDP2 O95551 3/20 0.72
SAE1 Q9UBE0 2/20 0.72
UBA2 Q9UBT2 2/20 0.72
RXFP1 Q9HBX9 1/20 0.72
MEN1 O00255 7/20 0.61
HTT P42858 5/20 0.61
SMN1; SMN2 Q16637 5/20 0.61
BLM P54132 5/20 0.61
HPGD P15428 4/20 0.61
LMNA P02545 4/20 0.61
THRB P10828 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6009826 0.84 KMT2A (1.00) APAF1KMT2ACASP3SENP8SENP7
SCHEMBL11354929 0.78 MAPT (0.58) APAF1KMT2ACASP3SENP8SENP7
SCHEMBL19065779 0.77 MAPT (0.79) KMT2AMAPTKDM4EHTTSMN1; SMN2
SCHEMBL13381749 0.76 CASP3 (1.00) APAF1KMT2ACASP3SENP8SENP7
SCHEMBL13021518 0.75 MAPT (0.58) APAF1KMT2ACASP3SENP8SENP7
SCHEMBL6350632 0.74 MAPT (0.59) APAF1KMT2ACASP3SENP8SENP7
SCHEMBL13224505 0.72 MAPT (0.89) KMT2AMAPTKDM4EMEN1HTT
SCHEMBL13021513 0.71 FABP4 (0.56) APAF1KMT2ACASP3SENP8SENP7
SCHEMBL8080715 0.71 PTPRC (0.54) MAPTKDM4ELMNAALDH1A1POLB
SCHEMBL15514574 0.71 CDC25B (0.55) KMT2AMAPTKDM4EHKDC1TDP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691418-B2 Composition for inhibiting or preventing the formation of a biofilm OYSTERSHELL NV (BE) 2010-04-06 US disclosed
US-20070258913-A1 Composition for Inhibiting or Preventing the Formation of a Biofilm OYSTERSHELL NV (BE) 2007-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070258913-A1 Composition for Inhibiting or Preventing the Formation of a Biofilm NQO2, NFKBIA, CROCC APAF1 3217/4885KMT2A 3594/4885CASP3 1330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.